Pacific Biosciences (PACB) Operatsion marja

Pacific Biosciences (PACB) brendining ramzi va logotipi

Pacific Biosciences (PACB) kompaniyasining haqiqiy operatsion marjasi biznes samaradorligini namoyish etadi, bunda -98.10 ushbu ko'rsatkichning bazaviy darajasini aks ettiradi. Pacific Biosciences (PACB) o'zining ESG tashabbuslari doirasida plastik chiqindilar va kimyoviy moddalarni minimallashtiradi. Emitentning barqarorligi yuqori darajada qolmoqda, garchi hukumat grantlari uskunalar xaridiga ta'sir ko'rsatishi mumkin bo'lsa-da. Kompaniya hozirda genom sekvenslash xarajatlarini kamaytirish va bioximiyani optimallashtirish uchun Revio tizimlarini faol joriy qilmoqda.

PACB: PacBio Sotuvning operatsion rentabelligi 04.07.2022 - 19.11.2026

Pacific Biosciences kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:PACB, PacBio Corp
PacBio Corp tayyor mahsulotlari

Operatsion marja moliyaviy xarajatlar va soliqlardan oldin umumiy tushumda asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Pacific Biosciences (PACB) uchun ushbu hisob-kitob Revio tizimlarining kengayish samaradorligini va bioximiya xarajatlarining optimallashtirilganini aks ettiradi. GURU.Markets platformasida operatsion foyda marjasini tahlil qilish orqali investor R&D siklining real vaqtdagi daromadlilik dinamikasini ko'rishi mumkin. Ushbu metrikaning o'sishi sekvenslash xarajatlarining kamayganini tasdiqlaydi, bu esa biznesning barqaror operatsion samaradorlikka o'tishidan dalolat beradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik